DNA methylation induced by DNMT3A has been shown to play a key role in chromatin accessibility and T-cell exhaustion, and the tumor killing effect of chimeric antigen receptor T-cell immunotherapy (CAR-T) after DNMT3A knockout is significantly enhanced [56, 57]. This evidence concerns the gene DNMT3A and neoplasm.